Cannevert Therapeutics Ltd. is a private company owned by a unique group of chemists, pharmacologists, and other medical professionals. With offices located on the campus of the University of British Columbia, CTL has obtained permission from Health Canada to conduct research on cannabis strains. Cannevert was established for the specific purpose of releasing the therapeutic potential of different cannabis cultivars in a clear, systematic and scientific manner. The company was founded by and consists of a group of academic scientists, some of whom are emeritus professors of pharmacology and anaesthesiology at UBC, experienced PhD scientists, and technical personnel. All are committed to the above specific goal. The various members of the team have a range of expertise, covering a wide area of relevant experience from many aspects of chemistry, to pharmacology, clinical expertise and clinical trials.


BIOTECHNOLOGY
THERAPEUTICS

Visit bctech for more information about Cannevert Therapeutics.